Specialty pharmaceutical company, Advanz Pharma, has launched a generic version of lanreotide, MYTOLAC, in Germany for the treatment of acromegaly, grade 1 and a subset of grade 2 ...

Alvotech and UK-based Advanz Pharma have broadened their commercial collaboration with an agreement to include three additional biosimilar candidates for commercialisation in Europe. The agreement ...

Alvotech, a global biotech company specializing in developing and manufacturing biosimilar medicines, and Advanz Pharma, a U.K.-headquartered global pharmaceutical company with a strategic focus ...

Alvotech and Advanz Pharma add three more biosimilars to collaboration. May 28, 2025 7:34 AM ET Alvotech (ALVO) Stock NVS, NVSEF By: Dulan Lokuwithana, SA News Editor. Play (1min) ...

Hg Capital LLP, Cinven and Advanz Pharma’s £100 million ($107 million) UK fine for excessive drug overcharging has been called “manifestly wrong” at a London court.. The pharmaceutical firm ...